{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:58Z","timestamp":1791302518443,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T00:00:00Z","timestamp":1389744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085430","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T21:32:38Z","timestamp":1389821558000},"page":"e85430","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort"],"prefix":"10.1371","volume":"9","author":[{"given":"Ga\u00eblle","family":"D\u00e9sam\u00e9ricq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dolbeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Youssov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Azulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tranchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Goizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Damier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Demonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graca","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent Cleret","family":"de Langavant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Macquin-Mavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Bachoud-L\u00e9vi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-126-5-199703010-00008","article-title":"Systematic reviews: critical links in the great chain of evidence","volume":"126","author":"CD Mulrow","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.clpt.6100249","article-title":"Developments in post-marketing comparative effectiveness research","volume":"82","author":"S Schneeweiss","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","article-title":"Psychopathology in verified Huntington's disease gene carriers","volume":"19","author":"E Van Duijn","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Mestre T, Ferreira J, Coelho MM, Rosa M, Sampaio C (2009) Therapeutic interventions for symptomatic treatment in Huntington's disease. Cochrane Database Syst Rev: CD006456. doi:10.1002\/14651858.CD006456.pub2.","DOI":"10.1002\/14651858.CD006456.pub2"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"CA Ross","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington's disease","volume":"27","author":"CS Venuto","year":"2012","journal-title":"Mov Disord"},{"key":"ref8","volume":"2","unstructured":"Orth M, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, et al<\/etal>.. (2010) Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr 2<\/volume> . Available:http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20890398<\/ext-link>. Accessed 21 February 2012."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/mds.22188","article-title":"A Europe-wide assessment of current medication choices in Huntington's disease","volume":"23","author":"J Priller","year":"2008","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.31.10.1333","article-title":"Huntington disease","volume":"31","author":"I Shoulson","year":"1981","journal-title":"Neurology"},{"key":"ref11","first-page":"136","article-title":"Mov Disord","volume":"11","year":"1996"},{"key":"ref12","unstructured":"WHO collaborating centre for drug statistics methodology (n.d.) WHOCC - ATC\/DDD Index. Available:http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>. Accessed 21 February 2012."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MLR.0b013e3181c1328f","article-title":"The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health","volume":"48","author":"MD Spreeuwenberg","year":"2010","journal-title":"Med Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.870100213","article-title":"Functional decline in Huntington's disease","volume":"10","author":"A Feigin","year":"1995","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870050202","article-title":"Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals","volume":"5","author":"JB Penney Jr","year":"1990","journal-title":"Mov Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mds.10718","article-title":"Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up","volume":"19","author":"JPP Van Vugt","year":"2004","journal-title":"Mov Disord"},{"key":"ref17","first-page":"366","article-title":"Neurology","volume":"66","author":"trial Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled","year":"2006"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group\/TETRA-HD Investigators","volume":"9","author":"S Frank","year":"2009","journal-title":"BMC Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002826-200209000-00007","article-title":"Olanzapine for Huntington's disease: an open label study","volume":"25","author":"RM Bonelli","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"ref20","first-page":"69","article-title":"Short-term effects of olanzapine in Huntington disease","volume":"14","author":"F Squitieri","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1600-0404.2002.01197.x","article-title":"Olanzapine in Huntington's disease","volume":"105","author":"D Paleacu","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington's disease: an evidence-based review","volume":"12","author":"RM Bonelli","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1468-1331.2002.0354e.x","article-title":"Risperidone in chorea and psychosis of Huntington's disease","volume":"9","author":"AK Erdemoglu","year":"2002","journal-title":"Eur J Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0004-282X2004000600030","article-title":"Functional and motor response to low dose olanzapine in Huntington's disease: case report","volume":"62","author":"J Laks","year":"2004","journal-title":"Arq Neuropsiquiatr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/jnnp.48.3.292","article-title":"Tiapride in 12 Huntington's disease patients","volume":"48","author":"N Quinn","year":"1985","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00004850-200403000-00001","article-title":"Huntington's disease: present treatments and future therapeutic modalities","volume":"19","author":"RM Bonelli","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2011.08.027","article-title":"Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study","volume":"503","author":"X Guo","year":"2011","journal-title":"Neurosci Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/mds.870110509","article-title":"Characteristics of individuals with Huntington disease in long-term care","volume":"11","author":"MA Nance","year":"1996","journal-title":"Movement Disorders"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"C Rummel-Kluge","year":"2010","journal-title":"Schizophr Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1212\/WNL.48.2.358","article-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders","volume":"48","author":"J Jankovic","year":"1997","journal-title":"Neurology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T08:03:04Z","timestamp":1589011384000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085430"}},"subtitle":[],"editor":[{"given":"Josef","family":"Priller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085430","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,15]]}}}